Preview

Regulatory Research and Medicine Evaluation

Advanced search

Method of simultaneous determination of carbamazepine and carbamazepine-10,11-epoxide by HPLC-MS/MS

Abstract

Carbamazepine is the drug of first choice in the treatment of trigeminal neuralgia, epilepsy and other neurological diseases. Carbamazepine is known to have a narrow therapeutic range, and hereby the auto-induction of its metabolism with prolonged use cause the reduction of its therapeutic efficacy. Phenotyping of patients by the rate of carbamazepine metabolism allows to perform individual drug dose adjustment and to avoid the occurrence of adverse drug effects. In order to implement the mentioned approach, the method for simultaneous determination of carbamazepine and carbamazepine-10,11-epoxide in human serum using HPLC-MS/MS was developed.

About the Authors

T. A. Rodina
Federal State Budgetary Institution «Scientific Center for Expert Evaluation of Medicinal Products» of the Ministry of Health of the Russian Federation, The Moscow Department of Health I.V. Davydovsky City Clinical Hospital
Russian Federation


E. S. Melnikov
I.M. Sechenov First Moscow State Medical University, The Moscow Department of Health I.V. Davydovsky City Clinical Hospital
Russian Federation


A. V. Sokolov
Federal State Budgetary Institution «Scientific Center for Expert Evaluation of Medicinal Products» of the Ministry of Health of the Russian Federation, I.M. Sechenov First Moscow State Medical University
Russian Federation


A. B. Prokofiev
Federal State Budgetary Institution «Scientific Center for Expert Evaluation of Medicinal Products» of the Ministry of Health of the Russian Federation, I.M. Sechenov First Moscow State Medical University,The Moscow Department of Health I.V. Davydovsky City Clinical Hospital
Russian Federation


V. V. Arkhipov
Federal State Budgetary Institution «Scientific Center for Expert Evaluation of Medicinal Products» of the Ministry of Health of the Russian Federation, I.M. Sechenov First Moscow State Medical University,The Moscow Department of Health I.V. Davydovsky City Clinical Hospital
Russian Federation


G. V. Adamov
M. Sechenov First Moscow State Medical University
Russian Federation


D. L. Pozdnyakov
The Moscow Department of Health I.V. Davydovsky City Clinical Hospital
Russian Federation


Yu. V. Olefir
Federal State Budgetary Institution «Scientific Center for Expert Evaluation of Medicinal Products» of the Ministry of Health of the Russian Federation
Russian Federation


References

1. Karlov VA. Treatment of nerve disease. Moscow: Meditsina; 2004 (in Russian).

2. Kukes VG, et al., eds. Therapeutic drug monitoring: tools of personalized medicine. Guidelines. Moscow: International Association of clinical pharmacologists and pharmacists; 2013 (in Russian).

3. Kukes VG, Grachev SV, Sychev DA, Ramenskaya GV. Metabolism of medicines. Scientific basis for personalized medicine. Guide for physicians. Moscow: GEOTAR-Media; 2008 (in Russian).

4. Kukes VG, ed. Directory of medicines metabolized in the human body. Moscow: International Association of clinical pharmacologists and pharmacists; 2013 (in Russian).

5. Holodov LE, Yakovlev VP. Clinical pharmacokinetics. Moscow: Meditsina; 1985 (in Russian).

6. Serralheiro A, Alves G, Fortuna A, Rocha M, Falcão A. First HPLC-UV method for rapid and simultaneous quantification of phenobarbital, primidone, phenytoin, carbamazepine, carbamazepine-10,11-epoxide, 10,11-transdihydroxy-10,11- dihydrocarbamazepine, lamotrigine, oxcarbazepine and licarbazepine in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Apr 15; 925.

7. Sato J, Saitoh T, Notani K, Fukuda H, Kaneyama K, Segami N. Diagnostic significance of carbamazepine and trigger zones in trigeminal neuralgia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004; PMID 14716252.

8. Patsalos PN, Berry DJ, Blaise F, Bourgeois D, Cloyd JC, Glauser TA, Johannessen SI, Leppik IE, Tomson T, Perucca E. Antiepileptic drugs – best practice guidelines for therapeutic drug monitoring: A position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies. Epilepsia 2008, 49(7): 1239–76.

9. Pisani F, Caputo M, Fazio A, Oteri G, Russo M, Spina E, Perucca E, Bertilsson L. Interaction of carbamazepine-10,11-epoxide, an active metabolite of carbamazepine, with valproate: a pharmacokinetic study. Epilepsia 1990; 31(3): 339–42.

10. Ranise A, Benassi E, Besio G. Rapid gas chromatography method for the determination of carbamazepine and unrearranged carbamazepine-10,11-epoxide in human plasma. J Chromatogr. 1981; 222: 120–4.

11. Cocks DA, Dyer TF, Edgar K. Simple and rapid gas-liquid chromatographic method for estimating carbamazepine in serum. J Chromatogr. 1981; 222: 496–500.

12. Chen K, Bashi HK. Comparative analysis of antiepileptic drugs by gas chromatography using capillary or packed columns and by fluorescence polarization immunoassay. J Anal Toxicol. 1991; 15: 82–5.

13. Hallbach J, Vogel H, Guder WG. Determination of Lamotrigine, Carbamazepine and Carbamazepine Epoxide in Human Serum by Gas Chromatography Mass Spectrometry. Munich: Institute for Clinical Chemistry, Bogenhausen Hospital; 1997.

14. Rouan MC, Campestrini J, Le Clanche V, et al. Automated microanalysis of carbamazepine and its epoxide and trans-diol metabolites in plasma by column liquid chromatography. J Chromatogr. 1992; 573: 65–8.

15. Ferreira A, Rodrigues M, Oliveira P, Francisco J, Fortuna A, Rosado L, Rosado P, Falcão A, Alves G. Liquid chromatographic assay based on microextraction by packed sorbent for therapeutic drug monitoring of carbamazepine, lamotrigine, oxcarbazepine, phenobarbital, phenytoin and the active metabolites carbamazepine- 10,11-epoxide and licarbazepine. Journal of Chromatography 2014; 971: 20–9.

16. Pienimaki P, Fuchs S, Isojarvi J, et al. Improved detection and determination of carbamazepine and oxcarbazepine and their metabolites by high-performance liquid chromatography. J Chromatogr. 1995; 673: 97–105.

17. Chan K. Simultaneous determination of carbamazepine and its epoxide metabolite in plasma and urine by high-performance liquid chromatography. J Chromatogr. 1985; 342: 341–7.


Review

For citations:


Rodina T.A., Melnikov E.S., Sokolov A.V., Prokofiev A.B., Arkhipov V.V., Adamov G.V., Pozdnyakov D.L., Olefir Yu.V. Method of simultaneous determination of carbamazepine and carbamazepine-10,11-epoxide by HPLC-MS/MS. The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products. 2015;(4):20-25. (In Russ.)

Views: 892


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 3034-3062 (Print)
ISSN 3034-3453 (Online)